Renaissance Pharma Ltd

About

Renaissance Pharma Ltd is a research-stage pharmaceutical company based in Hale, Greater Manchester, focused on developing treatments for rare paediatric diseases.

The company is part of Essential Pharma and is currently advancing Daretabart (hu14.18K322A), a humanised anti-GD2 antibody immunotherapy targeting high-risk neuroblastoma, a rare childhood cancer of the sympathetic nervous system.

Neuroblastoma accounts for approximately 10% of childhood cancers and represents a significant clinical need, particularly for patients with high-risk disease where survival rates remain low despite intensive therapy. Renaissance Pharma's investigational compound has demonstrated tolerability and clinical activity in Phase I and II trials and has received FDA Fast Track Designation, indicating accelerated development pathways toward potential regulatory approval.

Common questions

Where is Renaissance Pharma Ltd based?

Renaissance Pharma Ltd is based at Hale, Greater Manchester.

What does Renaissance Pharma Ltd do?

Renaissance Pharma Ltd is a Hale-based pharmaceutical research company developing Daretabart, an immunotherapy for high-risk neuroblastoma in children. The company is part of Essential Pharma and focuses on rare paediatric disease treatments.

What sector does Renaissance Pharma Ltd work in?

Renaissance Pharma Ltd works in the Research sector.

How can I contact Renaissance Pharma Ltd?

You can contact Renaissance Pharma Ltd through its website at https://renaissancepharma.co.uk.